Search

everythinglearnresearchcommunity

for

Search:↓

HPLC may detect prediabetes and diabetes earlier than Immunoturbidimetry because it shows higher A1c levels.

Psychiatrists are crucial in pain management teams because they help treat severe pain and related mental health issues.

The document concludes that Passiflora incarnata could help with anxiety, telemedicine might improve heart failure care, screen time for kids has increased, pregnant teens in Brazil are mostly okay with their body image, rare tuberculosis infection can occur after knee surgery, older and severely ill people are more likely to have long COVID-19 symptoms, HPLC might diagnose more diabetes cases, and psychiatrists should be involved in pain management.

Nursing staff's mental health was affected during the COVID-19 pandemic.

People with cleft lip and palate often have respiratory problems.

Girls with Autism Spectrum Disorder may show different symptoms than boys, leading to missed or delayed diagnoses.

Social media data can help track and predict COVID-19 symptoms and trends.

COVID-19 vaccines may cause hair loss in people who are genetically prone to it.

Many patients with hair loss had low iron and vitamin D levels, but thyroid issues were not common.

The structure of SRD5A reveals how it reduces steroids, aiding drug design for related health conditions.

The treatment improved hair growth and thickness in patients with hair loss, even 10 months after therapy without additional products.

COVID-19 can cause various skin issues in children, mostly not severe, with chilblain-like lesions being common, especially in adolescents.

COVID-19 may cause temporary hair loss due to direct damage to hair follicles, but it usually gets better on its own.

About a quarter of the participants experienced hair loss after COVID-19 vaccination.

About 61% of women who had COVID-19 experienced hair loss afterward.

Many patients experienced severe hair loss after COVID-19, especially older adults and women.

Injecting scalp tissue micrografts is a safe and effective treatment for hair loss after COVID-19.

Monocytes might be linked to hair loss after COVID-19.

Early treatment with certain drug combinations improved COVID-19 outcomes and prevented severe disease in males, including those at higher risk.

Men with male pattern baldness had worse COVID-19 symptoms, but early treatment with certain drugs improved outcomes for all.

A COVID-19 patient had severe and long-lasting skin issues and unusual hair loss.

Almost half of COVID-19 patients in Makkah, Saudi Arabia experienced increased hair loss, especially women and those with chronic diseases.

COVID-19 can cause hair loss starting as early as 18 days after infection.

A patient experienced severe hair loss after getting an mRNA COVID-19 vaccine.

Most COVID-19 patients in hospitals have androgenetic alopecia, more in men, suggesting a link between androgen sensitivity and severe COVID-19 symptoms.

Most severe COVID-19 patients in Mexico experienced long-lasting symptoms that worsened their quality of life.

A COVID-19 infected patient with chronic kidney disease experienced worsened kidney function, hair loss, and unexpected wart clearance.

COVID-19 can cause different types of hair loss, which may last up to 100 days, and treatments are still being explored.

Men and women get COVID-19 at similar rates, but men tend to get sicker and have a higher risk of dying, while women usually have stronger immune responses and vaccine reactions.

Proxalutamide significantly lowered hospitalization rates in women with mild-to-moderate COVID-19.